The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Genovese et al., N Engl J Med 353(11):1114-1123 September 15, 2005.

Correction
PreviousPrevious
Volume 353:2311 November 24, 2005 Number 21
NextNext

Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor {alpha} Inhibition

Since this article has no abstract, we have provided an extract of the first 100% of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Genovese, M. C.
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor {alpha} Inhibition . On page 1121, in Figure 3B, the key was incorrectly labeled. The light blue bars represent abatacept, and the dark blue bars placebo. We regret the error.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.